Xiang H.-F. Zhang

Baylor College of Medicine — United States

Medicine · Health Sciences

57h-index19.5kcitations330works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(71), Cancer Immunotherapy and Biomarkers(50), Bone health and treatments(34), Immune cells in cancer(31), Radiopharmaceutical Chemistry and Applications(24)

Publications324 total

Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers
Nature Communications·2026Open Access
Sticky neutrophils, risky tumors: NETs in DICER1-associated rhabdomyosarcoma
Developmental Cell·2026
Supplementary Video 2 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2<sup>+</sup> Cells
2025Open Access
Supplementary Video 3 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2<sup>+</sup> Cells
2025Open Access
Supplementary Video 4 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2<sup>+</sup> Cells
2025Open Access
Supplementary Raw Data from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2<sup>+</sup> Cells
2025Open Access
Supplementary Figure S1-S7 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2<sup>+</sup> Cells
2025Open Access
Supplementary Video 1 from Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2<sup>+</sup> Cells
2025Open Access
FGFR1-Activated Translation of WNT Pathway Components with Structured 5′ UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation
UNC Libraries·2025Open Access
Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 TherapeuticsPLK2 as a Biomarker for PLK1 Therapeutics
UNC Libraries·2025Open Access
Single application of controlled-release fertilizer at the seedling stage enhances grain yield and mitigates methane emissions in coastal saline soils
Frontiers in Sustainable Food Systems·2025Open Access
Supplementary Table 1 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure Legend from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 6 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 3 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 4 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 5 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 1 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 7 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 2 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
page 1 of 17Next →

Frequent Co-authors

Joan Massagué(13), Ik Sun Kim(7), Hai Wang(7), Jeffrey M. Rosen(7), Hin Ching Lo(6), Thomas F. Westbrook(6), Igor Bado(6), Weijie Zhang(6), Lawrence A. Chasin(5), William L. Gerald(4), Lin Tian(4), Amit Goldstein(4), Thomas Welte(4), Stephen T.C. Wong(4), Matthew J. Ellis(4), Cristina Nadal(3), Don X. Nguyen(3), John A. Foekens(3), Larry Norton(3), Xin Jin(3)